Navigation Links
Thalidomide may stage a comeback

The controversial drug thalidomide, which was banned in 1962, is being reassessed to find out if it could again be prescribed to patients to treat rare forms of cancer and leprosy. The drug which is unlicensed in Europe was marketed in the 50s and 60s as a cure for morning// sickness. However, it was banned after mothers who took it gave birth to deformed children.

The European Agency for the Evaluation of Medicinal Products (EMEA) is now considering whether the drug should be re-licensed for use across the EU, since recent studies have suggested that thalidomide could be a weapon in the fight against cancer and could help people with AIDS and other serious diseases. EMEA officials who met representatives of thalidomide victims as part of their consultation process, are focusing on the safeguards that would be needed if the drug is re-licensed.

The agency also suggested that even if the drug is approved, it will only be used on specific patients. These include patients diagnosed with multiple myeloma, a cancer of the bone marrow, which affects about 20,000 patients in Europe each year. Earlier, Dr. Claus Newman, a specialist in birth defects stated that thalidomide is a unique drug with powerful effects potentially for harm and good and its wider licensing will require extraordinary measures.


'"/>




Page: 1

Related medicine news :

1. Thalidomide is the new approved drug for treating multiple cancers
2. Thalidomide for Tumor Treatment
3. Frozen Canadian baby stages miraculous recovery
4. Surgery for early stage prostate cancer is better than waiting
5. Drug Tarceva for End-stage Lung cancer
6. Breast Cancer in younger women can be detected at an early stage by mammograms
7. Cancer cells were killed even at reduced dose of radiation therapy in early stage Hodgkin’s.
8. Herceptin is the cure for early stages of breast cancer?
9. Genes determine the capacity to fight HIV in early stages
10. Dialysis Trust Set Up in Bangalore by End-stage Kidney Patients
11. Combining Therapies can Improve Survival for Early-stage Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology: